PURPOSE: To evaluate the association between macula vascular density assessed by optical coherence tomography angiography (OCT-A) and central visual field (VF) threshold sensitivities in healthy, glaucoma suspect, and glaucoma patients. METHODS: A total of 185 eyes from 38 healthy participants, 31 glaucoma suspects, 72 mild glaucoma patients, and 44 moderate/severe glaucoma patients from the Diagnostic Innovations in Glaucoma Study who underwent OCT-A images of the macula and 10-2 VF testing were enrolled in this observational cross-sectional study. The relationship between central VF mean sensitivity (MS) and superficial macula whole-image vessel density (wiVD), and the relationship between the MS of the 4 central points of the 10-2 VF (MS4) and parafoveal vessel density (pfVD), were assessed using linear regression models. RESULTS: Mean wiVD (52.5%, 49.8%, 49.4% and 45.2%, respectively) and mean pfVD (54.9%, 52.1%, 51.8% and 47.7%, respectively) were found to be significantly higher in healthy eyes and glaucoma suspect eyes compared with glaucoma eyes with mild and moderate/severe disease [analysis of covariance (ANCOVA) P<0.001]. The univariate associations between 10-2 MS and wiVD (R=26.9%) and between 10-2 MS4 and pfVD (R=16.8%) were statistically significant (P<0.001 for both). After adjusting for scan quality, age, sex and intraocular pressure, superficial macula wiVD and pfVD were still independently associated with central VF loss. Macula wiVD performed better [area under the receiver operator characteristic (AUROC)=0.70] than ganglion cell complex thickness (AUROC=0.50) for differentiating between glaucoma suspect and healthy eyes (P=0.010). CONCLUSIONS: Loss of OCT-A macula vessel density is associated with central 10-2 VF defects. Macula vessel density is a clinically relevant parameter that may enhance monitoring of glaucoma suspects and patients.
PURPOSE: To evaluate the association between macula vascular density assessed by optical coherence tomography angiography (OCT-A) and central visual field (VF) threshold sensitivities in healthy, glaucoma suspect, and glaucomapatients. METHODS: A total of 185 eyes from 38 healthy participants, 31 glaucoma suspects, 72 mild glaucomapatients, and 44 moderate/severe glaucomapatients from the Diagnostic Innovations in Glaucoma Study who underwent OCT-A images of the macula and 10-2 VF testing were enrolled in this observational cross-sectional study. The relationship between central VF mean sensitivity (MS) and superficial macula whole-image vessel density (wiVD), and the relationship between the MS of the 4 central points of the 10-2 VF (MS4) and parafoveal vessel density (pfVD), were assessed using linear regression models. RESULTS: Mean wiVD (52.5%, 49.8%, 49.4% and 45.2%, respectively) and mean pfVD (54.9%, 52.1%, 51.8% and 47.7%, respectively) were found to be significantly higher in healthy eyes and glaucoma suspect eyes compared with glaucoma eyes with mild and moderate/severe disease [analysis of covariance (ANCOVA) P<0.001]. The univariate associations between 10-2 MS and wiVD (R=26.9%) and between 10-2 MS4 and pfVD (R=16.8%) were statistically significant (P<0.001 for both). After adjusting for scan quality, age, sex and intraocular pressure, superficial macula wiVD and pfVD were still independently associated with central VF loss. Macula wiVD performed better [area under the receiver operator characteristic (AUROC)=0.70] than ganglion cell complex thickness (AUROC=0.50) for differentiating between glaucoma suspect and healthy eyes (P=0.010). CONCLUSIONS: Loss of OCT-A macula vessel density is associated with central 10-2 VF defects. Macula vessel density is a clinically relevant parameter that may enhance monitoring of glaucoma suspects and patients.
Authors: Abtin Shahlaee; Wasim A Samara; Jason Hsu; Emil Anthony T Say; M Ali Khan; Jayanth Sridhar; Bryan K Hong; Carol L Shields; Allen C Ho Journal: Am J Ophthalmol Date: 2016-02-24 Impact factor: 5.258
Authors: Zaid Mammo; Morgan Heisler; Chandrakumar Balaratnasingam; Sieun Lee; Dao-Yi Yu; Paul Mackenzie; Steven Schendel; Andrew Merkur; Andrew Kirker; David Albiani; Eduardo Navajas; Mirza Faisal Beg; William Morgan; Marinko V Sarunic Journal: Am J Ophthalmol Date: 2016-07-25 Impact factor: 5.258
Authors: Harsha L Rao; Zia S Pradhan; Robert N Weinreb; Hemanth B Reddy; Mohammed Riyazuddin; Srilakshmi Dasari; Meena Palakurthy; Narendra K Puttaiah; Dhanaraj A S Rao; Carroll A B Webers Journal: Am J Ophthalmol Date: 2016-08-30 Impact factor: 5.258
Authors: Yali Jia; Eric Wei; Xiaogang Wang; Xinbo Zhang; John C Morrison; Mansi Parikh; Lori H Lombardi; Devin M Gattey; Rebecca L Armour; Beth Edmunds; Martin F Kraus; James G Fujimoto; David Huang Journal: Ophthalmology Date: 2014-03-12 Impact factor: 12.079
Authors: Hana L Takusagawa; Liang Liu; Kelly N Ma; Yali Jia; Simon S Gao; Miao Zhang; Beth Edmunds; Mansi Parikh; Shandiz Tehrani; John C Morrison; David Huang Journal: Ophthalmology Date: 2017-07-01 Impact factor: 12.079
Authors: Eren Ekici; Sasan Moghimi; Christopher Bowd; Huiyuan Hou; Rafaella C Penteado; James Proudfoot; Diya Yang; Robert N Weinreb Journal: Am J Ophthalmol Date: 2020-06-17 Impact factor: 5.258
Authors: Huiyuan Hou; Sasan Moghimi; James A Proudfoot; Elham Ghahari; Rafaella C Penteado; Christopher Bowd; Diya Yang; Robert N Weinreb Journal: Ophthalmology Date: 2020-01-13 Impact factor: 12.079
Authors: Rafaella Nascimento E Silva; Carolina A Chiou; Mengyu Wang; Julia Devlin; Dian Li; Sydney Lovelace; Haobing Wang; Scott H Greenstein; Stacey C Brauner; Lucy Q Shen Journal: Ophthalmol Glaucoma Date: 2020-10-16